Literature DB >> 15247254

Homo-oligomerization of ALS2 through its unique carboxyl-terminal regions is essential for the ALS2-associated Rab5 guanine nucleotide exchange activity and its regulatory function on endosome trafficking.

Ryota Kunita1, Asako Otomo, Hikaru Mizumura, Kyoko Suzuki, Junko Showguchi-Miyata, Yoshiko Yanagisawa, Shinji Hadano, Joh-E Ikeda.   

Abstract

Mutations in the ALS2 gene have been known to account for a juvenile recessive form of amyotrophic lateral sclerosis (ALS2), a rare juvenile recessive form of primary lateral sclerosis, and a form of hereditary spastic paraplegia (HSP), indicating that the ALS2 protein is essential for the maintenance of motor neurons. Recently, we have demonstrated that the ALS2 protein specifically binds to the small GTPase Rab5 and acts as a GEF (guanine nucleotide exchange factor) for Rab5. We have also shown that its Rab5GEF-requisite domain resides within the C-terminal 640-amino acid region spanning membrane occupation and recognition nexus motifs and the vacuolar protein sorting 9 domain. Transiently expressed ALS2 localized onto early endosomal compartments and stimulated endosome fusions in neuronal and non-neuronal cells in an Rab5GEF activity-dependent manner. These results indicate that the C-terminal region of ALS2 plays a crucial role in endosomal dynamics by its Rab5GEF activity. Here we delineate a molecular feature of the ALS2-associated function through the C-terminal region-mediated homo-oligomerization. A yeast two-hybrid screen for interacting proteins with the ALS2 C-terminal portion identified ALS2 itself. ALS2 forms a homophilic oligomer through its distinct C-terminal regions. This homo-oligomerization is crucial for the Rab5GEF activity in vitro and the ALS2-mediated endosome enlargement in the cells. Taken together, these results indicate that oligomerization of the ALS2 protein is one of the fundamental features for its physiological function involving endosome dynamics in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247254     DOI: 10.1074/jbc.M406120200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Complex genetics of amyotrophic lateral sclerosis.

Authors:  Catherine B Kunst
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

2.  Functional analyses of the plant-specific C-terminal region of VPS9a: the activating factor for RAB5 in Arabidopsis thaliana.

Authors:  Mariko Sunada; Tatsuaki Goh; Takashi Ueda; Akihiko Nakano
Journal:  J Plant Res       Date:  2016-01       Impact factor: 2.629

3.  Sequencing of random Euplotes crassus macronuclear genes supports a high frequency of +1 translational frameshifting.

Authors:  Lawrence A Klobutcher
Journal:  Eukaryot Cell       Date:  2005-12

4.  Clinical presentation and natural history of infantile-onset ascending spastic paralysis from three families with an ALS2 founder variant.

Authors:  Mayada Helal; Neda Mazaheri; Bita Shalbafan; Reza Azizi Malamiri; Nafi Dilaver; Rebecca Buchert; Javad Mohammadiasl; Neda Golchin; Alireza Sedaghat; Mohammad Yahya Vahidi Mehrjardi; Tobias B Haack; Olaf Riess; Wendy K Chung; Hamid Galehdari; Gholamreza Shariati; Reza Maroofian
Journal:  Neurol Sci       Date:  2018-08-21       Impact factor: 3.307

5.  Characterization of RIN3 as a guanine nucleotide exchange factor for the Rab5 subfamily GTPase Rab31.

Authors:  Hiroaki Kajiho; Kyoko Sakurai; Tomohiro Minoda; Manabu Yoshikawa; Satoshi Nakagawa; Shinichi Fukushima; Kenji Kontani; Toshiaki Katada
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

Review 6.  Molecular and cellular pathways of neurodegeneration in motor neurone disease.

Authors:  P J Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

Review 7.  Modelling amyotrophic lateral sclerosis in rodents.

Authors:  Tiffany W Todd; Leonard Petrucelli
Journal:  Nat Rev Neurosci       Date:  2022-03-08       Impact factor: 34.870

8.  Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking.

Authors:  Shinji Hadano; Asako Otomo; Ryota Kunita; Kyoko Suzuki-Utsunomiya; Akira Akatsuka; Masato Koike; Masashi Aoki; Yasuo Uchiyama; Yasuto Itoyama; Joh-E Ikeda
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

9.  A Toxoplasma MORN1 null mutant undergoes repeated divisions but is defective in basal assembly, apicoplast division and cytokinesis.

Authors:  Alexander Lorestani; Lilach Sheiner; Kevin Yang; Seth D Robertson; Nivedita Sahoo; Carrie F Brooks; David J P Ferguson; Boris Striepen; Marc-Jan Gubbels
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

10.  Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function.

Authors:  Kai Sato; Asako Otomo; Mahoko Takahashi Ueda; Yui Hiratsuka; Kyoko Suzuki-Utsunomiya; Junya Sugiyama; Shuji Murakoshi; Shun Mitsui; Suzuka Ono; So Nakagawa; Hui-Fang Shang; Shinji Hadano
Journal:  J Biol Chem       Date:  2018-09-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.